AxoGen announces closing of public offering of common stock
AxoGen announced the closing of its previously announced underwritten public offering of 805,000 shares sold by AxoGen and 1,150,000 shares sold by EW Healthcare Partners, at a price to the public of $21.00 per share. Total net proceeds are estimated to be $15.4 million. November 20, 2017